RE:RE:RE:RE:MMJ is safe, says WHO - how long will USA Rescheduling take?GTP,
GW Pharmaceuticals has applied for FDA approval of their CBD epilepsy drug Epidiolex. If accepted it would be the first cannabis formulated medication to receive FDA approval. From what I’ve read, by law the FDA/DEA will have 90 days to reschedule it from a schedule 1 drug after its approval. The approval and rescheduling of cannabis derived CBD would mean that for the very first time the US federal government would be admitting that CBD has medical value. The public pressure from media attention and the hypocrisy-surrounding schedule 1 will force the government to reschedule cannabis.
The FDA is expected to rule on Epidiolex sometime between May / July of 2018. If it gets approved, which many are expecting, this should act as a very strong catalyst to the cannabis industry and all pharm companies doing research that involves CBD. Hint… Kalytera.
If FDA approves GW's application in May/July of 2018 it will be the equivalent of throwing gasoline onto a fire when it comes to Canadian cannabis stocks. It will me a major catalyst if not a super catalyst for cannabis share prices in Canada that will already be on fire because of pending legalization.
Look for Cannabis to get rescheduled in the second half of 2018.
Happy new years to you and yours.
Monteviale
Gonetopot wrote: Sunny how sure can we be that the USA will make changes in 2018? Happy New Year to you and your family.